Search Results - "Beresnev, T"

Splenectomy Correlates With Worse Survival Independent of Disease Burden After Cytoreduction and Heated Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma by Schaub, N.P, Alimchandani, M, Quezado, M, Steinberg, S.M, Langan, R, Hughes, M.M, Beresnev, T, Bartlett, D.L, Libutti, S.K, Pingpank, J.F, Royal, R.E, Brcher, B, Pandalai, P, Phan, G.Q, Stojadinovich, A, Rudloff, U, Alexander, H.R, Avital, I

Get full text

Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial by Rudloff, Udo, Langan, Russell C., Mullinax, John E., Beane, Joal D., Steinberg, Seth M., Beresnev, Tatiana, Webb, Carole C., Walker, Melissa, Toomey, Mary Ann, Schrump, David, Pandalai, Prakash, Stojadinovic, Alexander, Avital, Itzhak

“…Background A prospective randomized trial was conducted to compare the impact of systemic chemotherapy versus multi‐modality therapy (complete cytoreductive…”
Get full text

Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms by Grover, Amelia C., Libutti, Steven K., Pingpank, James F., Helsabeck, Cynthia, Beresnev, Tatiana, Alexander, H. Richard

“…We report results of using isolated hepatic perfusion (IHP) in patients with advanced progressive liver metastases (LM) from pancreatic and gastrointestinal…”
Get full text

Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy by Alexander, H. Richard, Libutti, Steven K., Bartlett, David L., Pingpank, James F., Kranda, Karen, Helsabeck, Cynthia, Beresnev, Tatiana

“…BACKGROUND Many patients with colorectal carcinoma develop unresectable metastases confined to the liver that remain the life‐limiting component of disease…”
Get full text

Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal Chemotherapy by FELDMAN, Andrew L, LIBUTTI, Steven K, PINGPANK, James F, BARTLETT, David L, BERESNEV, Tatiana H, MAVROUKAKIS, Sharon M, STEINBERG, Seth M, LIEWEHR, David J, KLEINER, David E, ALEXANDER, H. Richard

“…Malignant mesothelioma (MM) arising in the peritoneal cavity is a rare neoplasm characterized by peritoneal progression and for which there are limited…”
Get full text